Scotia Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Scotia Capital's SYNH Position: Q2 2021 in Review
Scotia Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 36,391 shares — an estimated $2.76M sold.
Scotia Capital first reported a position in SYNH in Q2 2019 and held it in 5 quarters. The position peaked at $2.76M in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.
- Scotia Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
- Scotia Capital sold 36,391 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $2.76M.
- Scotia Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 5 quarters.
- Scotia Capital's Syneos Health, Inc. Class A Common Stock position peaked at $2.76M in Q1 2021.
- 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.
Based on Scotia Capital's 13F filing for Q2 2021, filed 12 Aug 2021.